Hologic Inc. logo

Hologic Inc. (0J5Q)

Market Closed
7 Apr, 16:02
LSE LSE
$
75. 61
+0.07
+0.0993%
$
- Market Cap
38.79 P/E Ratio
- Div Yield
31,964 Volume
3.91 Eps
$ 75.54
Previous Close
Add Transaction
Day Range
75.57 75.61
Year Range
64.69 86.55
Want to track 0J5Q and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0J5Q closed Tuesday higher at $75.61, an increase of 0.0993% from Monday's close, completing a monthly increase of 0.0728% or $0.05. Over the past 12 months, 0J5Q stock gained 1.4286%.
0J5Q is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.469%, based on the last three reports.
Hologic Inc. has completed 3 stock splits, with the recent split occurring on Apr 03, 2008.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

0J5Q Chart

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 3 months ago
HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?

HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?

Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.

Zacks | 3 months ago
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Zacks | 4 months ago

Hologic Inc. (0J5Q) FAQ

What is the stock price today?

The current price is $75.61.

On which exchange is it traded?

Hologic Inc. is listed on LSE.

What is its stock symbol?

The ticker symbol is 0J5Q.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Hologic Inc. ever had a stock split?

Hologic Inc. had 3 splits and the recent split was on Apr 03, 2008.

Hologic Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Stephen P. MacMillan CEO
LSE Exchange
436440101 CUSIP
United States Country
7,070 Employees
- Last Dividend
3 Apr 2008 Last Split
21 Jun 1990 IPO Date

Overview

Hologic, Inc. is a pioneering company focused on improving women’s health through early detection and treatment, leveraging advanced diagnostics, medical imaging systems, and surgical products. Founded in 1985 with its headquarters in Marlborough, Massachusetts, Hologic operates across four distinct segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its commitment to innovation and improving patient outcomes positions Hologic as a leader in the healthcare industry, ensuring it meets the diverse needs of healthcare providers and patients alike.

Products and Services

  • Aptima Molecular Diagnostic Assays: These assays are designed to detect infectious microorganisms, playing a crucial role in the diagnosis and management of infectious diseases.
  • Aptima Viral Load Assays: Specifies viral load measurements for Hepatitis B, Hepatitis C, HIV, and human cytomegalovirus, critical for monitoring and managing these infections.
  • Aptima Bacterial Vaginosis and Candida Vaginitis Assays: Offer diagnosis solutions for vaginitis, improving patient care through accurate detection.
  • Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 Assays: Enable the detection of SARS-CoV-2, the virus responsible for COVID-19, showcasing Hologic's capacity to respond to emergent health threats.
  • ThinPrep System: Provides cytology applications, enhancing the accuracy of Pap tests for detecting cervical cancer at early stages.
  • Rapid Fetal Fibronectin Test: Aids in assessing the risk of pre-term birth, offering critical information to healthcare providers for managing pregnancies.
  • 3D Digital Mammography Systems: Revolutionizes breast cancer detection with advanced imaging technology, improving the early diagnosis of breast cancer.
  • MyoSure Hysteroscopic Tissue Removal System: Allows for the minimally invasive removal of fibroids and polyps in the uterus, contributing to enhanced patient comfort and recovery.
  • NovaSure Endometrial Ablation System: Provides treatment for abnormal uterine bleeding, offering an effective alternative to more invasive surgical procedures.
  • Fluent Fluid Management System: Delivers liquid distention during hysteroscopic procedures, ensuring operational efficiency and safety.
  • Acessa ProVu System: A minimally invasive solution for treating fibroids, demonstrating Hologic’s commitment to innovative treatment options.
  • CoolSeal Portfolio: Features bipolar vessel sealing devices designed for surgical efficiency and patient safety during procedures.
  • Horizon DXA: This dual-energy X-ray absorptiometry system is used for assessing bone density, aiding in the detection and treatment of osteoporosis.
  • Fluoroscan Insight FD Mini C-arm: A compact imaging solution for orthopedic surgical procedures, enhancing the visualization needed for minimally invasive interventions.

Contact Information

Address: 250 Campus Drive
Phone: 508 263 2900